Skip to main content
Premium Trial:

Request an Annual Quote

CIRM Funds Dwindle

California's stem cell research agency may soon run out of funding, ScienceInsider reports.

The California Institute for Regenerative Medicine was established in 2004 following the passage of Proposition 71 and first began awarding grants in 2006. But as ScienceInsider reports, CIRM has announced that it has no more funding to award to new projects. At the end of June, the agency suspended application submissions until further notice, according to a note on its site.

"[T]here is no money available for new projects, whether it's discovery, translational, or clinical," CIRM's Kevin McCormack writes in a blog post.

ScienceInsider notes that the agency has sought bridge funding from private sources, though that has not been successful. There is also a push to again put stem cell research funding on the ballot in California with a $5.5 billion bond initiative, but ScienceInsider says its passage is not certain.

CIRM made California the "center of the stem cell universe. It would be tragic to unravel [that infrastructure] now," Jeanne Loring, who recently retired from the Scripps Research Institute and runs a biotech startup, tells it. "But the funding in 2004 was so dependent on the politics and interest at the time, and I don't know if those circumstances can be replicated."

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.